[Rapporto di ricerca] Il mercato del cuore strutturale è stato valutato a 14.245,55 milioni di dollari nel 2022 e si prevede che raggiungerà 22.560,88 milioni di dollari entro il 2028; Si stima che registrerà un CAGR dell'8,0% tra il 2022 e il 2028.
Il mercato del cuore strutturale è segmentato in base al prodotto, alla procedura, all'utente finale e all'area geografica. Il rapporto offre approfondimenti e analisi approfondite del mercato, sottolineando vari parametri quali dinamiche, tendenze e opportunità del mercato e analisi del panorama competitivo dei principali attori del mercato in varie regioni. Include anche un'analisi dell'impatto della pandemia COVID-19 sul mercato in tutte le regioni.
Mercato del cuore strutturale, approfondimenti strategici
Mercato del cuore strutturale, approfondimenti di mercato
Il numero crescente di casi di malattie cardiovascolari e i programmi di formazione guidano il mercato del cuore strutturale
Secondo l'Organizzazione Mondiale della Sanità (OMS), le malattie cardiovascolari sono la seconda causa di morte nel mondo. Pertanto si stanno adottando diverse iniziative per controllare l'incidenza delle malattie cardiovascolari. La malattia della valvola cardiaca è una delle cause più comuni di insufficienza cardiaca. Le malattie degenerative delle valvole aortica e mitrale e le malattie delle valvole tricuspide disfunzionali portano ad un decorso clinico peggiore nei casi gravi. Gli interventi mini-invasivi, chirurgici e cateterizzati per le cardiopatie strutturali sono aumentati notevolmente di recente. La scheda informativa del Regno Unito di gennaio 2022, pubblicata dalla British Heart Foundation (BHF), mostra che circa 7,6 milioni di persone con malattie cardiovascolari vivono nel Regno Unito. Secondo la stessa fonte, nel 2021 nel Paese sono state diagnosticate malattie cardiache e circolatorie a circa 4 milioni di uomini e circa 3,6 milioni di donne. A causa dell'elevata incidenza di malattie cardiovascolari, esiste una forte domanda di procedure terapeutiche come l'angioplastica e l'intervento cardiaco chirurgia per la sopravvivenza, che crea opportunità per le aziende di fornire valvole cardiache strutturali e anelli per annuloplastica, tra gli altri dispositivi.
Il cuore strutturale è un campo in evoluzione costituito da interventi chirurgici sulle valvole cardiache e procedure transcatetere; pertanto si stanno organizzando diversi programmi di formazione per cardiochirurghi e medici. Negli ultimi dieci anni, la crescente incidenza delle cardiopatie strutturali ha reso necessario lo sviluppo di programmi di formazione formale per garantire la competenza adeguata della forza lavoro. La struttura, la durata e la portata della formazione variano notevolmente tra i programmi. La maggior parte dei programmi fornisce una formazione efficace sulle procedure di sostituzione transcatetere della valvola aortica (TAVR), fornendo contemporaneamente un'esperienza minore e variabile sugli interventi di chiusura del difetto del setto interatriale o del setto ventricolare e di chiusura dell'appendice atriale sinistra. Con l'avvento della TAVR, del sistema di riparazione della valvola mitrale MitraClip (Abbott Vascular) e delle procedure di occlusione dell'appendice atriale sinistra (LAAO), si è verificato un aumento significativo del volume delle procedure cardiache strutturali eseguite per il trattamento di pazienti con patologie cardiovascolari complesse. Molte organizzazioni hanno sviluppato servizi e offerte procedurali in un formato organizzato per il programma cardiaco strutturale per accogliere l’afflusso di pazienti. La formazione in SHD è entusiasmante, stimolante e gratificante nel complesso. Con l’evoluzione del settore, la standardizzazione della formazione SHD diventa estremamente importante per garantire la migliore qualità della cura del paziente. Un mentore può aiutare a orientarsi tra le numerose considerazioni delineate e può essere la risorsa migliore per passare con successo dalla formazione alla pratica.
Di seguito è riportato l'elenco dei programmi di formazione disponibili negli Stati Uniti per le procedure cardiache strutturali:
Programmi di allenamento cardiaco strutturale negli Stati Uniti
Sr. No | Programma | Stato |
| < p>1 | Programma dell'Università di Washington Swedish Medical Center a Seattle, WA | Washington |
2 | Programma del sistema sanitario principale/centro medico Lankenau < p>Thomas Jefferson University Hospital | Pennsylvania |
3 | Programma del New York Presbyterian Hospital (Columbia Campus) NYU School of Medicine Langone Medical Center Icahn School of Medicine at Mount Sinai Lenox Hill Heart and Vascular Institute-Northwell Health Montefiore Medical Center L'Università di Buffalo - Università statale di New York | New York |
4 | Programma Duke University Hospital Programma UNC Medical Center | Carolina del Nord |
5 | Rutgers Robert Wood Johnson Medical School - New Brunswick, New Jersey Programma di borse di studio sulle malattie cardiache strutturali e congenite presso l'Hackensack University Medical Center e l'ospedale pediatrico Joseph M Sanzari Hackensack University Medical Center | New Jersey |
6 | Scripps Clinic/Scripps Green Hospital Program Sharp Healthcare Advanced Interventional and Structural Heart Fellowship Università della California, Davis, Programma sanitario Università della California, San Diego Università della California, San Francisco | California |
7 | Programma dell'Università del Maryland Programma della Johns Hopkins University | Maryland |
8 | Programma del William Beaumont Hospital Programma del Detroit Medical Center/Wayne State University Programma dell'Henry Ford Hospital/Wayne State University Ascension Borgess— Programma della Michigan State University Michigan Medicine: programma dell'Università del Michigan | Michigan |
Programma della Emory University | Georgia | |
10 | Programma Banner-University Medical Center Phoenix Tucson Medical Center/THMEP | Arizona |
Fonte: The Society for Cardiovascolare Angiography and Interventions (SCAI )
Pertanto, il numero crescente di casi di malattie cardiovascolari e i programmi di formazione sul cuore strutturale stanno alimentando la crescita del mercato del cuore strutturale.
Approfondimenti basati sul prodotto
In base al prodotto, il mercato del cuore strutturale è segmentato in occlusori, anelli per annuloplastica, palloncini per valvole cardiache e altri. Nel 2022, il segmento degli occlusori deteneva la quota maggiore del mercato del cuore strutturale; tuttavia, si prevede che il segmento degli anelli per annuloplastica registrerà il CAGR più elevato durante il periodo di previsione. Gli occlusori sono uno dei prodotti più comunemente utilizzati a causa della crescente prevalenza di difetti cardiaci congeniti come il difetto del setto atriale, il difetto del setto ventricolare, il dotto arterioso pervio e il forame ovale pervio. Gli occlusori aiutano nel trattamento dei difetti cardiaci congeniti attraverso procedure minimamente invasive, che forniscono opzioni di trattamento semplici e un rapido recupero ai pazienti.
Mercato del cuore strutturale, per prodotto: 2022-2028
Mercato del cuore strutturale, in base ad approfondimenti basati sulle procedure
In base alla procedura, il mercato del cuore strutturale è segmentato in stenosi della valvola cardiaca, sostituzione della valvola cardiaca e chiusura dell'appendice atriale sinistra . Nel 2022, il segmento della stenosi della valvola aortica deteneva la quota di mercato maggiore del mercato del cuore strutturale. Tuttavia, si prevede che il segmento di chiusura dell'appendice atriale sinistra registrerà il CAGR più elevato durante il periodo di previsione.
Mercato del cuore strutturale, in base ad approfondimenti basati sull'utente finale
In base all'utente finale, il Il mercato del cuore strutturale è segmentato in ospedali, centri chirurgici ambulatoriali e centri cardiaci. Il segmento ospedaliero deteneva la quota maggiore del mercato del cuore strutturale nel 2022 e si prevede che registrerà il CAGR più elevato durante il periodo di previsione.
Gli attori del mercato del cuore strutturale adottano strategie organiche, come il lancio e l'espansione del prodotto. , per espandere la propria presenza e il portafoglio di prodotti in tutto il mondo e soddisfare la crescente domanda. Le strategie di crescita inorganica testimoniate nel mercato sono partnership e collaborazioni. Queste strategie di crescita hanno consentito agli operatori del mercato di espandere le proprie attività e migliorare la propria presenza geografica. Inoltre, acquisizioni, partnership e altre strategie di crescita aiutano a rafforzare la base di clienti dell'azienda e ad aumentare il suo portafoglio di prodotti.
- Nel febbraio 2023, Medtronic ha rilanciato il suo Harmony Transcatheter Sistema di valvola polmonare (TPV), un'alternativa minimamente invasiva alla chirurgia a cuore aperto per pazienti con malattie cardiache congenite con tratto di efflusso del ventricolo destro (RVOT) nativo o riparato chirurgicamente.
- Nel novembre 2022, Boston Scientific Corporation ha rilasciato il primi risultati dello studio ACURATE neo2 Post Market Clinical Follow-up (PMCF) che valuta le prestazioni del sistema di valvola aortica ACURATE neo2TM. I risultati, che includevano un elevato tasso di successo procedurale del 98,4% e bassi tassi di mortalità e perdita paravalvolare (PVL), sono stati presentati durante una sessione di sperimentazione clinica dell'ultima ora al PCR London Valves 2022.
- Nell'ottobre 2022 , Il team del Centro medico femminile e pediatrico di Guangzhou ha impiantato con successo Memosorb in un bambino affetto da una malattia cardiaca congenita. Il completamento con successo di questa operazione segna che l'applicazione clinica dell'occlusore ha compiuto un passo essenziale nel sud della Cina, confermando ancora una volta la sicurezza e l'efficacia del Memosorb nel trattamento interventistico delle malattie cardiache congenite.
Mercato del cuore strutturale, profili aziendali
- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corp
- Artivion Inc.
- Edwards Lifesciences Corp
- Lepu Medical Technology Beijing Co Ltd
- Braile Biomédica Industry
- Commerce and Representations Ltd
- Aran Biomedical Teoranta
- Micro Interventional Devices Inc
- Corcym UK Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. Most structural heart conditions are present since birth (congenital), but these can also be acquired later in life owing to wear & tear from infection. Advancements in the medical field have replaced open-heart surgical procedures with minimally invasive procedures. The devices that are used in structural heart disease comprise replacement and repair devices, such as devices that are used for the treatment of heart-related diseases. Structural heart devices comprise annuloplasty rings and heart valve balloons occluders, among others.
The structural heart market is expected to be valued at US$ 22,560.88 million in 2028.
The structural heart market was valued at US$ 14,245.55 million in 2022.
The structural heart market majorly consists of the players, such as Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc., Edwards Lifesciences Corp, Lepu Medical Technology Beijing Co Ltd, Braile Biomédica Industry, Commerce and Representations Ltd, Aran Biomedical Teoranta, Micro Interventional Devices Inc, Corcym UK Ltd.
The factors driving the structural heart market growth, includes innovative structural heart services, and a rise in the number of cardiovascular procedures and corresponding training programs boost the market growth.
The market is estimated to grow at a CAGR of 8.0% during the forecast period.
The structural heart market, by product, is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest market share in 2022, however, annuloplasty rings is anticipated to register the highest CAGR in the market during the forecast period.
The List of Companies - Structural Heart Market
- ABBOTT
- MEDTRONIC
- BOSTON SCIENTIFIC CORPORATION
- CRYOLIFE, INC
- EDWARD LIFESCIENCES CORPORATION
- LEPU MEDICAL
- BRAILE BIOMEDICA
- ARAN BIOMEDICAL TEORANTA
- Micro Interventional Devices, Incorporated
- CORCYM
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2023
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2023
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2023
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography